Literature DB >> 20967817

Bioorthogonal small-molecule ligands for PARP1 imaging in living cells.

Thomas Reiner1, Sarah Earley, Anna Turetsky, Ralph Weissleder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20967817      PMCID： PMC3034378          DOI： 10.1002/cbic.201000477

Source DB:  PubMed          Journal:  Chembiochem        ISSN： 1439-4227            Impact factor:   3.164


× No keyword cloud information.
  12 in total

1.  PARP-1 and PARP-2 interact with nucleophosmin/B23 and accumulate in transcriptionally active nucleoli.

Authors:  Véronique S Meder; Marcel Boeglin; Gilbert de Murcia; Valérie Schreiber
Journal:  J Cell Sci       Date:  2005-01-01       Impact factor: 5.285

Review 2.  PARP inhibition: PARP1 and beyond.

Authors:  Michèle Rouleau; Anand Patel; Michael J Hendzel; Scott H Kaufmann; Guy G Poirier
Journal:  Nat Rev Cancer       Date:  2010-03-04       Impact factor: 60.716

Review 3.  Inhibition of poly(ADP)-ribose polymerase as a therapeutic strategy for breast cancer.

Authors:  Elizabeth A Comen; Mark Robson
Journal:  Oncology (Williston Park)       Date:  2010-01       Impact factor: 2.990

4.  Bioorthogonal turn-on probes for imaging small molecules inside living cells.

Authors:  Neal K Devaraj; Scott Hilderbrand; Rabi Upadhyay; Ralph Mazitschek; Ralph Weissleder
Journal:  Angew Chem Int Ed Engl       Date:  2010-03-19       Impact factor: 15.336

Review 5.  Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology.

Authors:  Kapila Ratnam; Jennifer A Low
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

6.  Tetrazine-based cycloadditions: application to pretargeted live cell imaging.

Authors:  Neal K Devaraj; Ralph Weissleder; Scott A Hilderbrand
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

7.  Fast and sensitive pretargeted labeling of cancer cells through a tetrazine/trans-cyclooctene cycloaddition.

Authors:  Neal K Devaraj; Rabi Upadhyay; Jered B Haun; Scott A Hilderbrand; Ralph Weissleder
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

8.  PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites.

Authors:  Jean-François Haince; Darin McDonald; Amélie Rodrigue; Ugo Déry; Jean-Yves Masson; Michael J Hendzel; Guy G Poirier
Journal:  J Biol Chem       Date:  2007-11-19       Impact factor: 5.157

9.  A photochemical synthesis of functionalized trans-cyclooctenes driven by metal complexation.

Authors:  Maksim Royzen; Glenn P A Yap; Joseph M Fox
Journal:  J Am Chem Soc       Date:  2008-03-06       Impact factor: 15.419

10.  A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage.

Authors:  Sherif F El-Khamisy; Mitsuko Masutani; Hiroshi Suzuki; Keith W Caldecott
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971
View more
  30 in total

1.  In vivo imaging of drug-induced mitochondrial outer membrane permeabilization at single-cell resolution.

Authors:  Sarah Earley; Claudio Vinegoni; Joshua Dunham; Rostic Gorbatov; Paolo Fumene Feruglio; Ralph Weissleder
Journal:  Cancer Res       Date:  2012-04-13       Impact factor: 12.701

2.  Bioorthogonal imaging of aurora kinase A in live cells.

Authors:  Katherine S Yang; Ghyslain Budin; Thomas Reiner; Claudio Vinegoni; Ralph Weissleder
Journal:  Angew Chem Int Ed Engl       Date:  2012-05-29       Impact factor: 15.336

3.  Fluorine-18 labeled poly (ADP-ribose) polymerase1 inhibitor as a potential alternative to 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in oral cancer imaging.

Authors:  Paula Demétrio de Souza França; Sheryl Roberts; Susanne Kossatz; Navjot Guru; Christian Mason; Daniella Karassawa Zanoni; Marcio Abrahão; Heiko Schöder; Ian Ganly; Snehal G Patel; Thomas Reiner
Journal:  Nucl Med Biol       Date:  2020-01-23       Impact factor: 2.408

4.  Harnessing the bioorthogonal inverse electron demand Diels-Alder cycloaddition for pretargeted PET imaging.

Authors:  Thomas Reiner; Jason S Lewis; Brian M Zeglis
Journal:  J Vis Exp       Date:  2015-02-03       Impact factor: 1.355

5.  In vivo imaging of specific drug-target binding at subcellular resolution.

Authors:  J M Dubach; C Vinegoni; R Mazitschek; P Fumene Feruglio; L A Cameron; R Weissleder
Journal:  Nat Commun       Date:  2014-05-28       Impact factor: 14.919

Review 6.  Intravital imaging.

Authors:  Mikael J Pittet; Ralph Weissleder
Journal:  Cell       Date:  2011-11-23       Impact factor: 41.582

Review 7.  Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.

Authors:  Carlos Tassa; Stanley Y Shaw; Ralph Weissleder
Journal:  Acc Chem Res       Date:  2011-06-10       Impact factor: 22.384

8.  Non-invasive PET Imaging of PARP1 Expression in Glioblastoma Models.

Authors:  Brandon Carney; Giuseppe Carlucci; Beatriz Salinas; Valentina Di Gialleonardo; Susanne Kossatz; Axel Vansteene; Valerie A Longo; Alexander Bolaender; Gabriela Chiosis; Kayvan R Keshari; Wolfgang A Weber; Thomas Reiner
Journal:  Mol Imaging Biol       Date:  2016-06       Impact factor: 3.488

9.  BODIPY-tetrazine derivatives as superbright bioorthogonal turn-on probes.

Authors:  Jonathan C T Carlson; Labros G Meimetis; Scott A Hilderbrand; Ralph Weissleder
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-27       Impact factor: 15.336

10.  Bioorthogonal approach to identify unsuspected drug targets in live cells.

Authors:  Katherine S Yang; Ghyslain Budin; Carlos Tassa; Olivier Kister; Ralph Weissleder
Journal:  Angew Chem Int Ed Engl       Date:  2013-08-19       Impact factor: 15.336
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.